Skip to content

Clinical study on the application of remifentanil tosylate in anesthesia induction and maintenance during joint replacement surgery in elderly patients

Clinical study on the application of remifentanil tosylate in anesthesia induction and maintenance during joint replacement surgery in elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102723
Enrollment
Unknown
Registered
2025-05-19
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The state of elderly patients receiving anesthesia during joint replacement surgery

Interventions

Test group:Anesthesia induction protocol: remifentanil tosylate 0.15-0.3mg/kg+sufentanil 0.3-0.5 µ g/kg+rocuronium bromide 0.6mg/kg Anesthesia maintenance plan: Inhalation of sevoflurane 1%+remifentan
control group:Anesthesia induction protocol: intravenous injection of propofol 1.0-2.5 mg/kg+sufentanil 0.3-0.5 µ g/kg+rocuronium bromide 0.6mg/kg Anesthesia maintenance plan: inhalation of sevofluran

Sponsors

The First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 74 Years

Inclusion criteria

Inclusion criteria: (1) Age>=60 years and =18.5 kg/m² and <28 kg/m²; (5) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Severe heart, brain, liver and kidney diseases; (2) Psychiatric diseases (including but not limited to schizophrenia, mania, etc.) or long-term use of psychotropic drugs; (3) Allergy or contraindication to benzodiazepines, propofol, opioids or muscle relaxants; (4) Modified Mahalanobis score of IV; (5) Participated in other drug clinical trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure (MAP);Heart rate (HR);Respiratory rate (RR);bispectral index(BIS value);

Secondary

MeasureTime frame
Patient awakening time and duration of stay in PACU;Preoperative and postoperative cognitive function assessment of patients ;Adverse event occurrence and use of vasoactive drugs;Total length of hospital stay;

Countries

China

Contacts

Public ContactYangJuan

The First Affiliated Hospital of Kunming Medical University

yangjuan@kmmu.edu.cn+86 182 0888 0755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026